$10.18
-0.34-3.23%
At close: -
$10.18
0.000.00%
After Hours: Mar 7, 4:00 PM EDT
Comments
Loading...
Myriad Genetics Earnings Estimates, EPS & Revenue | NASDAQ:MYGN | Benzinga
Myriad Genetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$0.000
Quarterly Revenue Estimate
$212.84M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$837.60M
Analyze the earnings history of Myriad Genetics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Myriad Genetics (MYGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-24 | $0.03 | $0.03 | 0.00 % |
| Q3 | 2024-11-07 | $0.06 | $0.02 | 200.0 % |
| Q2 | 2024-08-06 | $0.05 | $-0.01 | 600.0 % |
| Q1 | 2024-05-07 | $-0.01 | $-0.10 | 90.0 % |
Myriad Genetics (MYGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-24 | $210.60M | $210.35M | 0.12 % |
| Q3 | 2024-11-07 | $213.30M | $210.73M | 1.22 % |
| Q2 | 2024-08-06 | $211.50M | $204.95M | 3.20 % |
| Q1 | 2024-05-07 | $202.20M | $193.26M | 4.63 % |
FAQ
When is Myriad Genetics (NASDAQ:MYGN) reporting earnings?
Myriad Genetics (MYGN) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 24, 2025 for Q4.
What were the latest earnings per share (EPS) for Myriad Genetics (NASDAQ:MYGN)?
The Actual EPS was $0.03, which hit the estimate of $0.03.
What were Myriad Genetics’s (NASDAQ:MYGN) revenues?
The Actual Revenue was $210.6M, which beat the estimate of $210.3M.
Browse earnings estimates, EPS, and revenue on all stocks.